相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New compounds for a good old class: Synthesis of two B-lactam bearing cephalosporins and their evaluation with a multidisciplinary approach
Giovanni Vigliotta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units
Alyssa R. Golden et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Recent advances in the development ofβ-lactamase inhibitors
Shivakumar S. Jalde et al.
JOURNAL OF MICROBIOLOGY (2020)
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens
Jacinda C. Abdul-Mutakabbir et al.
PHARMACOTHERAPY (2020)
Antimicrobial Activity of Calixarenes and Related Macrocycles
Dmitriy N. Shurpik et al.
MOLECULES (2020)
Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum Gram-negative antibiotics
Yun-Ming Lin et al.
BIOMETALS (2019)
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2019)
Drug combinations: a strategy to extend the life of antibiotics in the 21 st century
Mike Tyers et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug
Lindsay E. Evans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis
Landys Lopez Quezada et al.
ACS INFECTIOUS DISEASES (2019)
Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?
Kokob H. Negash et al.
MOLECULES (2019)
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
Malcom G. P. Page
CLINICAL INFECTIOUS DISEASES (2019)
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
Yoshinori Yamano
CLINICAL INFECTIOUS DISEASES (2019)
Antibiotics: past, present and future
Matthew I. Hutchings et al.
CURRENT OPINION IN MICROBIOLOGY (2019)
An overview of recent progress in siderophore-antibiotic conjugates
Huimin Kong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
James A. Karlowsky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M. Kazmierczak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Calixarenes: Generalities and Their Role in Improving the Solubility, Biocompatibility, Stability, Bioavailability, Detection, and Transport of Biomolecules
Edilma Sanabria Espanol et al.
BIOMOLECULES (2019)
New β-lactam - Tetramic acid hybrids show promising antibacterial activities
Philip T. Cherian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Ronald Domalaon et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Stability and low induction propensity of cefiderocol against chromosomal AmpC beta-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
Akinobu Ito et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic
Rui Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Supramolecular Organocatalysis in Water Mediated by Macrocyclic Compounds
Margherita De Rosa et al.
FRONTIERS IN CHEMISTRY (2018)
Stability of cefiderocol against clinically significant broad-spectrum oxacillinases
Laurent Poirel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Computational analysis of the interactions of a novel cephalosporin derivative with β-lactamases
Anna Verdino et al.
BMC STRUCTURAL BIOLOGY (2018)
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
Akinobu Ito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics
Philip T. Cherian et al.
JOURNAL OF ANTIBIOTICS (2017)
Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
J. Dobias et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis
Anna Verdino et al.
PLOS ONE (2017)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A Simple Tetraminocalix[4] arene as a Highly Efficient Catalyst under On-Water Conditions through Hydrophobic Amplification of Weak Hydrogen Bonds
Margherita De Rosa et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Functionalized calix[4]arenes as potential therapeutic agents
Muhammad Moazzam Naseer et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Tsukasa Ito-Horiyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Hybrid antibiotics - clinical progress and novel designs
Alastair L. Parkes et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor
Andrew P. Tomaras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Novel Penicillin-Type Analogues Bearing a Variable Substituted 2-Azetidinone Ring at Position 6: Synthesis and Biological Evaluation
Margherita De Rosa et al.
MOLECULES (2015)
Design of dual action antibiotics as an approach to search for new promising drugs
A. N. Tevyashova et al.
RUSSIAN CHEMICAL REVIEWS (2015)
Synthesis and Antimicrobial Studies of Novel Imidazole Containing Bisazetidinones and Bisthiazolidinone Derivatives
Ramakanth Pagadala et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2015)
Enterobactin-Mediated Delivery of β-Lactam Antibiotics Enhances Antibacterial Activity against Pathogenic Escherichia coli
Tengfei Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Synthesis and Antimicrobial Evaluation of Novel Bis-β-lactam Grafted Macrocycles
Natarajan Arumugam et al.
MEDICINAL CHEMISTRY (2014)
Calixcephems: clustered cephalosporins analogous to calixpenams as novel potential anti-MRSA agents
Fazel Nasuhi Pur et al.
TURKISH JOURNAL OF CHEMISTRY (2014)
Calixpenams: synthesis, characterization, and biological evaluation of penicillins V and X clustered by calixarene scaffold
Fazel Nasuhi Pur et al.
TURKISH JOURNAL OF CHEMISTRY (2014)
Naturally occurring tetramic acid products: isolation, structure elucidation and biological activity
Xuhua Mo et al.
RSC ADVANCES (2014)
Siderophore conjugates
Malcolm G. P. Page
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa
Andrew P. Tomaras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Macrocycle-embedded β-lactams as novel inhibitors of the Penicillin Binding Protein PBP2a from MRSA
Georges Dive et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Harzianic acid: a novel siderophore from Trichoderma harzianum
Francesco Vinale et al.
FEMS MICROBIOLOGY LETTERS (2013)
Antistaphylococcal Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic
Johanne Blais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacodynamics of TD-1792, a Novel Glycopeptide-Cephalosporin Heterodimer Antibiotic Used against Gram-Positive Bacteria, in a Neutropenic Murine Thigh Model
Sharath S. Hegde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections
Martin E. Stryjewski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activity of TD-1792, a Multivalent GlycopeptideCephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species
Kerin L. Tyrrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In vitro activity of BAL30072 against Burkholderia pseudomallei
Takehiko Mima et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii
Thomas A. Russo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The phytotoxicity of natural tetramic acid derivatives
Huaping Zhao et al.
PEST MANAGEMENT SCIENCE (2011)
In Vitro Activity of the New Multivalent Glycopeptide-Cephalosporin Antibiotic TD-1792 against Vancomycin-Nonsusceptible Staphylococcus Isolates
Kimberly D. Leuthner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
Malcolm G. P. Page et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Chemistry and biology of siderophores
Robert C. Hider et al.
NATURAL PRODUCT REPORTS (2010)
Origins and Evolution of Antibiotic Resistance
Julian Davies et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2010)
Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa
Seungil Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin Trojan Horse antibiotics and synthetic desferridanoxamine-antibiotic conjugates
Timothy A. Wencewicz et al.
BIOMETALS (2009)
Sideromycins: tools and antibiotics
Volkmar Braun et al.
BIOMETALS (2009)
Novel heterodimer antibiotics: a review of recent patent literature
Daniel D. Long et al.
FUTURE MEDICINAL CHEMISTRY (2009)
A Multivalent Approach to Drug Discovery for Novel Antibiotics
Daniel D. Long et al.
JOURNAL OF ANTIBIOTICS (2008)
Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers
Daniel D. Long et al.
JOURNAL OF ANTIBIOTICS (2008)
Synthesis and biological evaluation of bile acid dimers linked with 1,2,3-triazole and bis-β-lactam
Namdev S. Vatmurge et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Dual action-based approaches to antibacterial agents
John B. Bremner et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by β-lactamases
GW Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Synthesis and antibacterial activity of new antibiotics arising from cephalosporin-monobactam coupling
M Panunzio et al.
ARKIVOC (2004)
Why is big Pharma getting out of antibacterial drug discovery?
SJ Projan
CURRENT OPINION IN MICROBIOLOGY (2003)
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against β-lactamase-producing strains
Q Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A trimer of phenoxymethyl penicillin sulphone:: Synthesis of a new β-lactam podand
A Agócs et al.
JOURNAL OF ANTIBIOTICS (2002)
Cephalosporin podand derivatives
A Kovács-Kulyassa et al.
JOURNAL OF ANTIBIOTICS (2000)
Giuseppe Brotzu and the discovery of cephalosporins
G Bo
CLINICAL MICROBIOLOGY AND INFECTION (2000)
分享论文
